← All members · Key votes
H.R. 10369 · 119th Congress
Net Effective Cost Transparency and Prescription Drug Affordability Act of 2026
Introduced / in committeeHealth Details
- Sponsor
- Ryan Mackenzie (R)
- Introduced
- 2026-09-14
- Origin
- House
- Policy area
- Health
- Latest action
- 2026-09-14 — Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Cosponsors
- 4
congress.gov
